中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2010年
10期
667-671
,共5页
王娟%胡大一%李新明%忻元峰%周华%王丽洁%王乐民%徐文俊
王娟%鬍大一%李新明%忻元峰%週華%王麗潔%王樂民%徐文俊
왕연%호대일%리신명%흔원봉%주화%왕려길%왕악민%서문준
心脏缺损,先天性%基因%转录因子
心髒缺損,先天性%基因%轉錄因子
심장결손,선천성%기인%전록인자
Heart defects,congenital%Genes%Transcription factors
目的 识别先天性心脏病(CHD)患者新的分子病因.方法 收集120例特发性CHD患者的临床资料和血标本,以100名健康者为对照.应用聚合酶链反应扩增GATA4基因的全部外显子,采用双脱氧核苷链末端合成终止法对全部扩增片段进行测序.借助BLAST程序将所测序列与GenBank中的已知序列进行比对以识别基因突变,并用Clustal W 软件分析突变氨基酸的保守性.结果 3例CHD患者的GATA4基因各识别出1个新的杂合错义突变,即第90、95和329位的密码子分别由AGC、GAC和AAG变为AGA、GAG和AAT,导致第90、95和329位的氨基酸分别由丝氨酸、天冬氨酸和赖氨酸变为精氨酸、谷氨酸和天冬酰胺,即S90R、D95E和K329N突变.这些突变在正常对照者中均不存在,多物种GATA4序列比对显示第329位的赖氨酸在进化上高度保守.此外,还发现了1个不改变氨基酸的单核甘酸多态,即c.99 G>T多态,但这些多态在CHD患者和健康对照者间的频率分布差异无统计学意义(P>0.05).结论 特发性CHD具有显著的遗传异质性,GATA4基因突变可能是部分特发性CHD患者的分子病因.
目的 識彆先天性心髒病(CHD)患者新的分子病因.方法 收集120例特髮性CHD患者的臨床資料和血標本,以100名健康者為對照.應用聚閤酶鏈反應擴增GATA4基因的全部外顯子,採用雙脫氧覈苷鏈末耑閤成終止法對全部擴增片段進行測序.藉助BLAST程序將所測序列與GenBank中的已知序列進行比對以識彆基因突變,併用Clustal W 軟件分析突變氨基痠的保守性.結果 3例CHD患者的GATA4基因各識彆齣1箇新的雜閤錯義突變,即第90、95和329位的密碼子分彆由AGC、GAC和AAG變為AGA、GAG和AAT,導緻第90、95和329位的氨基痠分彆由絲氨痠、天鼕氨痠和賴氨痠變為精氨痠、穀氨痠和天鼕酰胺,即S90R、D95E和K329N突變.這些突變在正常對照者中均不存在,多物種GATA4序列比對顯示第329位的賴氨痠在進化上高度保守.此外,還髮現瞭1箇不改變氨基痠的單覈甘痠多態,即c.99 G>T多態,但這些多態在CHD患者和健康對照者間的頻率分佈差異無統計學意義(P>0.05).結論 特髮性CHD具有顯著的遺傳異質性,GATA4基因突變可能是部分特髮性CHD患者的分子病因.
목적 식별선천성심장병(CHD)환자신적분자병인.방법 수집120례특발성CHD환자적림상자료화혈표본,이100명건강자위대조.응용취합매련반응확증GATA4기인적전부외현자,채용쌍탈양핵감련말단합성종지법대전부확증편단진행측서.차조BLAST정서장소측서렬여GenBank중적이지서렬진행비대이식별기인돌변,병용Clustal W 연건분석돌변안기산적보수성.결과 3례CHD환자적GATA4기인각식별출1개신적잡합착의돌변,즉제90、95화329위적밀마자분별유AGC、GAC화AAG변위AGA、GAG화AAT,도치제90、95화329위적안기산분별유사안산、천동안산화뢰안산변위정안산、곡안산화천동선알,즉S90R、D95E화K329N돌변.저사돌변재정상대조자중균불존재,다물충GATA4서렬비대현시제329위적뢰안산재진화상고도보수.차외,환발현료1개불개변안기산적단핵감산다태,즉c.99 G>T다태,단저사다태재CHD환자화건강대조자간적빈솔분포차이무통계학의의(P>0.05).결론 특발성CHD구유현저적유전이질성,GATA4기인돌변가능시부분특발성CHD환자적분자병인.
Objective To identify the novel genetic determinants in patients with congenital heart disease(CHD).Methods The clinical data and peripheral venous blood samples from 120 unrelated individuals with idiopathic CHD were collected and evaluated compared to 100 unrelated healthy controls.The complete coding exons and the partial flanking introns of GATA4 gene were amplified by polymerase chain reaction and sequenced by di-deoxynucleotide chain termination.The generated sequences were aligned with those retrieyed from GenBank with the aid of programme BLAST to identify the sequence variations.The software Clustal W was utilized to analyze the conservation of altered amino acids.Results Three novel heterozygous missense CATA4 mutations were identified in 3 of 120 CHD cases. Namely,the triplet substitutions of AGA for AGC at codon 90,GAG for GAC at codon 95,and AAT for AAG at codon 329,predicting the conversions of serine into arginine at amino acid residue 90(S90R),aspartic acid into glutamic acid at amino acid residue 95(D95E)and lysine into agparagine at amino acid residue 329 (K329N), were detected.None of these three mutations were probed in 100 controls.A cross-species alignment of GATA4 encoded protein sequences displayed that the lysine at amino acid residue 329 was completely conserved evolutionarily.Additionally.a single nucleotide polymorphism c.99G>T was observed.However.the polymorphic frequency distribution in CHD patients was not statistically different from that in controls (for genotypes,χ~2=0.2640,P=0.6074;for alleles,χ~2=0.2514,P=0.6161). Conclusion The idiopathic CHD has a marked heterogeneity and the mutated GATA4.A4 gene may be responsible for CHD in a subset of patients.